Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anish Thomas

Showing results (81-90 of 167) with videos related to

Pageof 17
Sort By:
Scientific Reports|December 9, 2014
Mutations of epigenetic regulatory genes are common in thymic carcinomasYisong Wang, Anish Thomas, Christopher Lau, et al.
Journal of Cellular Biochemistry|June 22, 2010
Expression of a novel tropomyosin isoform in axolotl heart and skeletal muscleAnish Thomas, Sudarsan Rajan, Harold L Thurston, et al.
AIDS Research and Human Retroviruses|October 9, 2010
Short communication: no evidence of HTLV-3 and HTLV-4 infection in New York State subjects at risk for retroviral infectionRaisa Perzova, Patricia Benz, Lynn Abbott, et al.
JTO Clinical and Research Reports|October 18, 2021
Phase 2 Study of Olaparib in Malignant Mesothelioma and Correlation of Efficacy With Germline or Somatic Mutations in <i>BAP1</i> GeneAzam Ghafoor, Idrees Mian, Cathy Wagner, et al.
AIDS Research and Human Retroviruses|January 6, 2010
LGL leukemia and HTLVAnish Thomas, Raisa Perzova, Lynn Abbott, et al.
Oncotarget|June 2, 2015
High mesothelin expression in advanced lung adenocarcinoma is associated with KRAS mutations and a poor prognosisAnish Thomas, Yuanbin Chen, Seth M Steinberg, et al.
Science Translational Medicine|October 25, 2013
Major cancer regressions in mesothelioma after treatment with an anti-mesothelin immunotoxin and immune suppressionRaffit Hassan, Andrew C Miller, Elad Sharon, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 19, 2014
Phase II clinical trial of amatuximab, a chimeric antimesothelin antibody with pemetrexed and cisplatin in advanced unresectable pleural mesotheliomaRaffit Hassan, Hedy L Kindler, Thierry Jahan, et al.
Science Translational Medicine|July 3, 2020
Enhanced efficacy of mesothelin-targeted immunotoxin LMB-100 and anti-PD-1 antibody in patients with mesothelioma and mouse tumor modelsQun Jiang, Azam Ghafoor, Idrees Mian, et al.
Lung Cancer (Amsterdam, Netherlands)|October 31, 2016
Expression of mesothelin in thymic carcinoma and its potential therapeutic significanceAnish Thomas, Yuanbin Chen, Arlene Berman, et al.
Pageof 17

Showing results (81-90 of 167) with videos related to

Sort By:
Pageof 17
Scientific Reports|December 9, 2014
Mutations of epigenetic regulatory genes are common in thymic carcinomasYisong Wang, Anish Thomas, Christopher Lau, et al.
Journal of Cellular Biochemistry|June 22, 2010
Expression of a novel tropomyosin isoform in axolotl heart and skeletal muscleAnish Thomas, Sudarsan Rajan, Harold L Thurston, et al.
AIDS Research and Human Retroviruses|October 9, 2010
Short communication: no evidence of HTLV-3 and HTLV-4 infection in New York State subjects at risk for retroviral infectionRaisa Perzova, Patricia Benz, Lynn Abbott, et al.
JTO Clinical and Research Reports|October 18, 2021
Phase 2 Study of Olaparib in Malignant Mesothelioma and Correlation of Efficacy With Germline or Somatic Mutations in <i>BAP1</i> GeneAzam Ghafoor, Idrees Mian, Cathy Wagner, et al.
AIDS Research and Human Retroviruses|January 6, 2010
LGL leukemia and HTLVAnish Thomas, Raisa Perzova, Lynn Abbott, et al.
Oncotarget|June 2, 2015
High mesothelin expression in advanced lung adenocarcinoma is associated with KRAS mutations and a poor prognosisAnish Thomas, Yuanbin Chen, Seth M Steinberg, et al.
Science Translational Medicine|October 25, 2013
Major cancer regressions in mesothelioma after treatment with an anti-mesothelin immunotoxin and immune suppressionRaffit Hassan, Andrew C Miller, Elad Sharon, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 19, 2014
Phase II clinical trial of amatuximab, a chimeric antimesothelin antibody with pemetrexed and cisplatin in advanced unresectable pleural mesotheliomaRaffit Hassan, Hedy L Kindler, Thierry Jahan, et al.
Science Translational Medicine|July 3, 2020
Enhanced efficacy of mesothelin-targeted immunotoxin LMB-100 and anti-PD-1 antibody in patients with mesothelioma and mouse tumor modelsQun Jiang, Azam Ghafoor, Idrees Mian, et al.
Lung Cancer (Amsterdam, Netherlands)|October 31, 2016
Expression of mesothelin in thymic carcinoma and its potential therapeutic significanceAnish Thomas, Yuanbin Chen, Arlene Berman, et al.
Pageof 17